RepliCel Life Sciences Inc.

OTCPK:REPC.F Lagerbericht

Marktkapitalisierung: US$65.0

RepliCel Life Sciences Management

Management Kriterienprüfungen 3/4

RepliCel Life Sciences' CEO is Andrew Schutte, appointed in Nov 2022, has a tenure of 5.92 years. directly owns 26.77% of the company’s shares, worth $17.40. The average tenure of the management team and the board of directors is 2 years and 5.9 years respectively.

Wichtige Informationen

Andrew Schutte

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführer2yrs
Eigentum des Geschäftsführers26.8%
Durchschnittliche Amtszeit des Managements2yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder5.9yrs

Jüngste Management Updates

Recent updates

Geschäftsführer

Andrew Schutte (34 yo)

2yrs

Amtszeit

CA$8,917

Vergütung

Mr. Andrew Schutte serves as President, Chief Executive Officer & Director of RepliCel Life Sciences Inc. since November 28, 2022. He served as an Independent Director of RepliCel Life Sciences Inc. since...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Andrew Schutte
President2yrsCA$8.92k26.77%
$ 17.4
Kevin McElwee
Co-Founder & Chief Scientific Officer13.3yrsCA$30.00k2.04%
$ 1.3
Ben Austring
Chief Legal Officer2yrsCA$14.50k0.49%
$ 0.3
David Kwok
Chief Financial Officer1.3yrskeine Datenkeine Daten

2.0yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrenes Management: REPC.F's management team is considered experienced (2 years average tenure).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Andrew Schutte
President5.9yrsCA$8.92k26.77%
$ 17.4
David Hall
Independent Chairman of the Board13.9yrsCA$17.75k1.35%
$ 0.9
Jean Krutmann
Member of Clinical Advisory Boardno datakeine Datenkeine Daten
Ross Davidson
Chairman of Clinical Advisory Board11.1yrskeine Datenkeine Daten
Peter Lewis
Independent Director13.5yrsCA$14.45k0.96%
$ 0.6
R. Buckler
Director8.8yrsCA$240.85k0.010%
$ 0.007
Gary Boddington
Independent Director3.4yrsCA$16.25k0.48%
$ 0.3
Jamie MacKay
Director1.3yrskeine Daten15.44%
$ 10.0
Tsukasa Kumai
Member of Clinical Advisory Boardno datakeine Datenkeine Daten
Akimichi Morita
Member of Clinical Advisory Board3.5yrskeine Datenkeine Daten
Kunihiko Suzuki
Senior Strategic Advisor to Directors3.1yrskeine Datenkeine Daten

5.9yrs

Durchschnittliche Betriebszugehörigkeit

61.5yo

Durchschnittliches Alter

Erfahrener Vorstand: REPC.F's board of directors are considered experienced (5.9 years average tenure).